Registry for individuals with microcephalic primordial dwarfism
Official title: Primordial Dwarfism Registry at Nemours Children's Hospital, Delaware
Run by Nemours Children's Clinic · NCT04569149 · Data updated 2026-11-12
This study is collecting information about people with microcephalic primordial dwarfism to better understand their conditions and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Nemours Children's Clinic Academic / other |
| Locations | 1 site (Wilmington, Delaware) |
| Status | Recruiting |
| Started | March 11, 2008 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT04569149 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals diagnosed with MOPDII, MOPDI/III, Meier-Gorlin syndrome, or closely related types of microcephalic primordial dwarfism.
✕Probably not a fit
Patients without a diagnosis of microcephalic primordial dwarfism or closely related conditions will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to collect comprehensive information on individuals diagnosed with various forms of microcephalic primordial dwarfism, including MOPDII and associated syndromes. By gathering data from medical records, the study seeks to establish a detailed natural history of these conditions, which may help identify risk factors and improve care. Participation involves no additional clinic visits or procedures, as it focuses solely on chart reviews after obtaining informed consent.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of microcephalic primordial dwarfism, enhancing the quality of life for affected individuals.
How similar studies have gone: While this registry approach is not novel, it builds on previous efforts to understand rare conditions, which have shown success in improving patient care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals with MOPDII, Meier-Gorlin syndrome, IMAGe syndrome, RNU4atac-opathies (MOPDI/III, Roifman syndrome, Lowry-Wood syndrome), LIG4 syndrome, and other classified as well as unclassified types of microcephalic primordial dwarfism and related conditions, as diagnosed by a medical provider, are eligible for this registry. Exclusion Criteria: * individuals without microcephalic primordial dwarfism or closely related conditions
Where it's running
-
Nemours
Wilmington, Delaware, United States Recruiting
Study contacts
- Principal investigator: Angela Duker, MS — Nemours
- Study coordinator: Angela Duker, MS, CGC
- Email: aduker@nemours.org
- Phone: 302-651-4181
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pacifier-Activated Lullaby to support oral feeding in preterm infants
This study tests whether a pacifier-activated lullaby system helps preterm babies move from tube feeding to feeding by mouth.
-
Toolkits to help providers deliver Diabetes Coaching to adolescents with Type 1 diabetes
This study tests whether groups of implementation tools can help pediatric diabetes and psychology teams at a Delaware hospital deliver Diabetes Coaching to more families.
-
Lidocaine During Surgery to See If It Lowers Opioid Use in Kids with Arm Fractures
In children aged 3–18 having surgery for upper-extremity fractures, this study tests whether giving IV lidocaine during the operation reduces the amount of opioid pain medicine needed after surgery.
-
Ultrasound to find elbow fractures in children
This trial tests whether using bedside ultrasound instead of X-rays helps children who come to the ER with elbow pain.
-
GLP-1 medication effects on reproductive hormones in obese teenage girls with PCOS
We will test whether GLP-1 medications are linked to changes in reproductive hormones and menstrual cycles in obese adolescent girls with PCOS.
-
Auryzon EAR 2.0 to shape cartilage for ear reconstruction
This test will try the Auryzon EAR 2.0 device to shape rib cartilage and help surgeons build anatomically accurate ears for children and young adults (ages 5–20) with microtia or other ear deformities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.